ADC THERAPEUTICS SA (ADCT) Forecast, Price Target & Analyst Ratings

NYSE:ADCT • CH0499880968

Current stock price

3.73 USD
+0.01 (+0.27%)
At close:
3.73 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADC THERAPEUTICS SA (ADCT).

Forecast Snapshot

Consensus Price Target

Price Target
$8.36
+ 124.24% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.22
Revenue Estimate
19.944M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.36
Upside
+ 124.24%
From current price of $3.73 to mean target of $8.36, Based on 12 analyst forecasts
Low
$6.06
Median
$8.16
High
$10.50

Price Target Revisions

1 Month
2.50%
3 Months
2.50%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for ADCT. The average price target is 8.36 USD. This implies a price increase of 124.24% is expected in the next year compared to the current price of 3.73.
The average price target has been revised upward by 2.5% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ADCT Current Analyst RatingADCT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

ADCT Historical Analyst RatingsADCT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.67%
ADCT was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ADCT.
In the previous month the buy percentage consensus was at a similar level.
ADCT was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-23HC Wainwright & Co.Maintains Buy -> Buy
2025-10-16HC Wainwright & Co.Maintains Buy -> Buy
2025-08-13GuggenheimReiterate Buy -> Buy
2025-06-20RBC CapitalMaintains Outperform -> Outperform
2025-06-13GuggenheimMaintains Buy -> Buy
2025-05-15RBC CapitalReiterate Outperform -> Outperform
2025-03-31GuggenheimMaintains Buy -> Buy
2025-03-31HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-07Cantor FitzgeraldReiterate Overweight -> Overweight
2025-02-24Stephens & Co.Maintains Overweight -> Overweight
2025-01-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-12GuggenheimReiterate Buy -> Buy
2024-12-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-08Stephens & Co.Initiate Overweight
2024-08-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-07RBC CapitalReiterate Outperform -> Outperform
2024-05-30Cantor FitzgeraldInitiate Overweight
2024-05-07HC Wainwright & Co.Maintains Buy -> Buy
2024-04-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-05GuggenheimReiterate Buy
2024-03-28GuggenheimInitiate Buy
2024-03-14RBC CapitalReiterate Outperform -> Outperform
2024-03-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-26RBC CapitalMaintains Outperform -> Outperform
2024-02-20HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.22
Revenue Estimate
19.944M
Revenue Q2Q
-13.41%
EPS Q2Q
39.08%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
3.91%
Revenue (3 Months)
4.56%
EPS (1 Month)
18.87%
EPS (3 Months)
21.82%

Next Earnings Summary

ADCT is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.22 USD and the consensus revenue estimate is 19.94M USD.
The next earnings revenue estimate has been revised upward by 4.56% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ADCT revenue by date.ADCT revenue by date.
69.558M
-66.86%		70.837M
1.84%		81.357M
14.85%		79.626M
-2.13%		132.57M
66.49%		292.08M
120.32%		320.18M
9.62%		376.44M
17.57%		400.65M
6.43%
EBITDA
YoY % growth
ADCT ebitda by date.ADCT ebitda by date.
-164.799M
-38.99%		-129.32M
21.53%		-107.674M
16.74%		-162.18M
-50.62%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
ADCT ebit by date.ADCT ebit by date.
-165.986M
-37.29%		-130.654M
21.29%		-108.379M
17.05%		-92.426M
14.72%		-75.02M
18.83%		59.198M
178.91%		17.879M
-69.80%		61.226M
242.45%		73.178M
19.52%
Operating Margin
ADCT operating margin by date.ADCT operating margin by date.
-238.63%-184.44%-133.21%-116.08%-56.59%20.27%5.58%16.26%18.26%
EPS
YoY % growth
ADCT eps by date.ADCT eps by date.
-2.93
-45.77%		-1.65
43.69%		-1.08
34.55%		-1.10
-1.53%		-0.70
36.37%		N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.22
39.08%		-0.21
44.08%		-0.22
25.20%		-0.22
-456.74%
Revenue
Q2Q % growth		19.944M
-13.41%		19.38M
2.87%		18.754M
14.17%		21.855M
-5.22%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-22.381M
21.37%		-22.444M
27.73%		-23.591M
22.88%		-22.03M
-20.60%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ADCT Yearly Revenue VS EstimatesADCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
ADCT Yearly EPS VS EstimatesADCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
52.62%
Revenue Next 5 Year
35.58%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ADC THERAPEUTICS SA / ADCT Forecast FAQ

What do analysts expect the price target to be for ADC THERAPEUTICS SA (ADCT)?

12 analysts have analysed ADCT and the average price target is 8.36 USD. This implies a price increase of 124.24% is expected in the next year compared to the current price of 3.73.

Can you provide the upcoming earnings date for ADC THERAPEUTICS SA?

ADC THERAPEUTICS SA (ADCT) will report earnings on 2026-05-12.

What are the consensus estimates for ADCT stock next earnings?

The consensus EPS estimate for the next earnings of ADC THERAPEUTICS SA (ADCT) is -0.22 USD and the consensus revenue estimate is 19.94M USD.

What is the consensus rating for ADCT stock?

The consensus rating for ADC THERAPEUTICS SA (ADCT) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.